Wockhardt Limited said that it has signed a collaboration agreement through its subsidiary with Serum Life Sciences Ltd, UK, which in turn is a subsidiary of the Serum Institute of India, for delivering a global vaccine program from its new facility in the UK.

The collaboration will lead to a profit sharing arrangement between the two parties that will be delivering up to an additional 150 million vaccine doses of various vaccines each year.

  Serum Institute of India, Serum Life Sciences, Wockhardt